[18F]GTP1, an experimental PET imaging agent, may allow doctors to see changes in the brains of individuals who have problems with thinking and memory related to Alzheimer’s disease. This study is an open-label study to evaluate the distribution of microdoses of [18F]GTP1 in the body in healthy volunteers of Japanese descent. Data from this study will support future clinical studies of Alzheimer’s disease in diverse patient populations.
Study Location: New Haven, Connecticut
You may be eligible to participate if you are:
The study involves:
**Stipend reimbursement up to $1000**
Subjects will be reimbursed for any reasonable travel-related expenses. For more information, please contact us by phone or email at: 1-800-401-6067 or Recruitment@invicro.com.